Mcule’s new ULTIMATE database has been
recently made available on Pharmit’s virtual screening platform. Scientists can
now utilize this excellent synergy to use the platform for carrying out structure-based
pharmacophore modeling and virtual screening. With 122 million novel compounds,
ULTIMATE is an excellent database to search when scaffold hopping, navigating
out of patented space, or identifying new chemotypes.
“We are very happy that Pharmit has integrated ULTIMATE,
and hope that the whole scientific community will benefit from this integration” - Robert Kiss, CEO of Mcule
“ULTIMATE is an excellent complement to our platform,
Pharmit users will surely find it useful for their projects” - David Koes, Assistant Professor at University of
Pittsburgh
About Mcule:
Mcule
is a chemical marketplace for drug discovery with services based around
small-molecule compound sourcing. While the traditional Mcule database
aggregates chemical suppliers to cover the “in stock” chemical space, ULTIMATE
contains 122 million novel compounds that can be delivered with an 80% success
rate in 2-6 weeks and have fixed prices. The company also provides solutions
for sample preparation, solubility inspection, and independent QC analysis.
About Pharmit:
Pharmit
provides an online, interactive environment for the virtual screening of large
compound databases using pharmacophores, molecular shape, and energy
minimization. It enables users to search for small molecules based on their
structural and chemical similarity to another small molecule, with the goal of
identifying those that bind to a target molecule (typically a protein receptor
or enzyme).
Please visit the Pharmit and
ULTIMATE website for more information:
